Dark

Check out our Level2View

ARYBU
ARYA Sciences Acquisition Corp II Unit
stock NASDAQ

Inactive

Oct 27, 2020

10.39USD-1.048%(-0.11)717

Pre-market

0.00USD0.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Oct 28, 2020

07:00AM EDT Business combination transaction with Arya Sciences Acquisition Corp II, a special purpose acquisition company sponsored by Perceptive Advisors, completed on October 27, 2020 GlobeNewswire Inc

Oct 21, 2020

12:34PM EDT ARYA Sciences Acquisition Corp II Announces Extraordinary General GlobeNewswire Inc

Sep 1, 2020

07:11PM EDT WeissLaw LLP Reminds MVC and ARYBU Shareholders About Its Ongoing Investigations PR Newswire

Aug 14, 2020

07:55PM EDT SHAREHOLDER ALERT: WeissLaw LLP Investigates Arya Sciences Acquisition Corp II PR Newswire

Jul 30, 2020

07:27AM EDT Cerevel Therapeutics Reports Business Combo With Arya Sciences Acquisition Corp. II; Upon Completion, Combined $445M In Expected Net Proceeds From PIPE, Cash Held In Arya II's Trust Account Will Be Used To Advance Development Of Cerevel's Neurosciene Pipe Benzinga

07:01AM EDT Cerevel Therapeutics and Arya Sciences Acquisition Corp II Announce Business Combination, Creating a Publicly Listed Leader in Neuroscience Drug Development Business Wire

Jul 22, 2020

04:32PM EDT ARYA Sciences Acquisition Corp II Announces the Separate Trading GlobeNewswire Inc

Share